Exelixis, Inc.

EXEL·NasdaqGS·Healthcare
Compare
59.82−0.04 (−0.07%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours59.63−0.19 (−0.32%)Oct 12, 4:25 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close59.86
Open60.48
Day range59.8061.66
52-week range33.7661.66
Off day high−2.98%
Off 52-week high−2.98%
Volume3.13M
Avg. volume (3M)2.33M
Market cap14.82B
EPS (TTM)3.17
Forward P/E14.00
P/E ratio (TTM)18.87
Dividend yield—
Beta (5Y)0.47
Shares outstanding247.78M
Short interest15.55% of float
Earnings dateAug 5, 2026
Analyst target54.87
Profit margin35.33%

Against its peers

Compare in full ›
EXEL SMMT RCUS ERAS GMAB IDYA
Market cap 14.82B 13.67B 3.06B 5.41B 22.98B 3.48B
P/E (TTM) 18.9 — — — 29.4 —
Forward P/E 14.0 -15.0 -7.5 -24.8 24.5 -9.0
Price/book 8.1 21.6 6.7 13.4 3.7 2.9
Dividend yield — — — — — —
1-year change +55.72% −23.29% +46.69% +567.92% +13.43% +34.89%
Today −0.07% −2.62% −0.29% −3.56% +0.81% −0.14%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Exelixis's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Summit Therapeutics Inc.SMMT · Biotechnology 13.67B 17.13 −2.62%
Arcus Biosciences, Inc.RCUS · Biotechnology 3.06B 24.34 −0.29%
Erasca, Inc.ERAS · Biotechnology 5.41B 15.46 −3.56%
Genmab A/SGMAB · Biotechnology 22.98B 37.37 +0.81%
IDEAYA Biosciences, Inc.IDYA · Biotechnology 3.48B 36.06 −0.14%
Celcuity Inc.CELC · Biotechnology 3.22B 65.85 −3.08%
Cogent Biosciences, Inc.COGT · Biotechnology 5.17B 29.78 −3.94%
ORIC Pharmaceuticals, Inc.ORIC · Biotechnology 1.22B 11.81 −1.50%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Ascendis Pharma A/SASND · Hellerup, Denmark 14.94B 227.00 −0.97%
Jazz Pharmaceuticals plcJAZZ · Dublin, Ireland 14.07B 216.75 −0.76%
Summit Therapeutics Inc.SMMT · Miami, FL 13.67B 17.13 −2.62%
Corcept Therapeutics IncorporatedCORT · Redwood City, CA 13.10B 121.19 0.00%
BridgeBio Pharma, Inc.BBIO · Palo Alto, CA 12.85B 65.75 +0.61%
Halozyme Therapeutics, Inc.HALO · San Diego, CA 12.61B 111.08 +0.60%
Bio-Techne CorporationTECH · Minneapolis, MN 11.38B 72.56 +0.14%
Vaxcyte, Inc.PCVX · San Carlos, CA 11.04B 70.65 −1.02%

Also based in Alameda, California, then elsewhere in California.

Company Mkt cap Price Today
Penumbra, Inc.PEN · Alameda, CA 12.64B 320.96 +0.49%
Scribe Therapeutics Inc.SCTX · Alameda, CA 391.32M 20.67 −2.36%
Vivani Medical, Inc.VANI · Alameda, CA 107.34M 1.1900 −4.80%
NVIDIA CorporationNVDA · Santa Clara, CAOdds 5.46T 226.32 −1.29%
Apple Inc.AAPL · Cupertino, CAOdds 4.98T 340.97 +1.29%
Alphabet Inc.GOOG · Mountain View, CA 4.27T 348.97 +0.32%
Meta Platforms, Inc.META · Menlo Park, CAOdds 1.89T 742.96 +3.38%
Broadcom Inc.AVGO · Palo Alto, CAOdds 1.69T 354.73 −1.88%

The stocks whose daily moves over the past year went most closely with Exelixis's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Incyte CorporationINCY · Correlation 0.49 22.57B 111.36 −1.27%
Neurocrine Biosciences, Inc.NBIX · Correlation 0.46 14.37B 141.37 −0.75%
Mirum Pharmaceuticals, Inc.MIRM · Correlation 0.42 5.59B 86.06 +0.06%
Genmab A/SGMAB · Correlation 0.38 22.98B 37.37 +0.81%
Acadia Pharmaceuticals Inc.ACAD · Correlation 0.35 3.34B 19.41 −1.87%
Vertex Pharmaceuticals IncorporatedVRTX · Correlation 0.33 128.50B 507.00 −0.60%
Halozyme Therapeutics, Inc.HALO · Correlation 0.31 12.61B 111.08 +0.60%

What visitors to Exelixis's page also look at.

Company Mkt cap Price Today
Incyte CorporationINCY 22.57B 111.36 −1.27%
BioMarin Pharmaceutical Inc.BMRN 10.72B 55.39 +1.09%
ACADIA Pharmaceuticals Inc.ACAD 3.34B 19.41 −1.87%
Neurocrine Biosciences, Inc.NBIX 14.37B 141.37 −0.75%
Vertex Pharmaceuticals IncorporVRTX 128.50B 507.00 −0.60%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All EXEL news ›
MarketScreener·

FDA Extends Review of Exelixis' Zanzalintinib in Colorectal Cancer

Published on 09/11/2026 at 07:51 am EDT Exelixis said the Food and Drug Administration has extended its review of the company's proposed zanzalintinib cancer drug by three months. Exelixis, which is seeking FDA approval zanzalintinib in…

Pluang·

Exelixis Inc. Common Stock (EXEL) Stock Price Today

EXEL Stock Fundamentals & Key Ratios Pluang Track Exelixis Inc. Common Stock (EXEL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Exelixis Inc. Common Stock has traded between a…

Trefis·

Is Exelixis Stock Engineered To Make You Money?

Exelixis (EXEL) stock has returned 46% over the past twelve months, compared with 17.8% for the S&P 500. The company has aggressively repurchased its own stock, reducing its total share count by 21% over the last three years. Because fewer…

MarketScreener·Negative

US FDA extends review of Exelixis' cancer drug

The U.S. Food and Drug Administration has extended the review of Exelixis' experimental colorectal cancer drug combination by three months, the company said in a filing on Friday. The... Biotechnology & Medical Research US FDA extends…

From articles in the 4Search news index.

In the news

11mentions in 30 days
7with it in the headline
Mixedsentiment

Mentioned with

Exelon4Expeditors4Royal Bank of Canada4Expeditors International of Washington3Investors & News3Morgan Stanley3Morgan Stanley Adjusts Price Target on Exelon3Barclays2

People in the coverage

Danessa Lincoln6Mitch Edgeman5Benzinga4Marketbeat4GE Vernova3Kim Johansen3

Themes

Healthcare4Consensus3EPS3Industrial3Ratings3Dpr2Earnings2Equities2

Most coverage from

  1. marketscreener.com3
  2. themarketsdaily.com2
  3. opi.net1
  4. pluang.com1
  5. theglobeandmail.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.